کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3355617 | 1217194 | 2012 | 6 صفحه PDF | دانلود رایگان |
Many means in inbred rodent models promoted long-term graft survival or donor-specific tolerance, but less so in nonhuman primates, outbred rodents or human patients. A diverse repertoire of memory T cells, derived from heterologous immunity or prior to exposure to alloantigen, has been believed to be an important part of this barrier. Memory T cells have a unique capacity to generate effector functions quickly upon re-exposure to antigen, and this capacity is achieved by reduced activation thresholds, and expressed high level trafficking and adhesion molecules, which is likely responsible for their exhibiting differential susceptibility to immune therapeutics compared with naïve T cells. This review outlines recent progress on characteristics of memory T cells and focuses on these potential therapies targeting memory T cells which are likely to ameliorate allograft rejection by inducing transplant tolerance.
► Donor-specific TMs contributed to graft destruction and resisted tolerance induction.
► TMs developed differential susceptibility to immunodepressant in contrast to TNs.
► Tol-DCs could induce tolerance of TMs.
► Tregs could potentially induce tolerance of recipient allo-reactive TMs.
Journal: Immunology Letters - Volume 148, Issue 1, November–December 2012, Pages 53–58